| ²é¿´: 1163 | »Ø¸´: 3 | ||||
| ±¾Ìû²úÉú 1 ¸ö MolEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿»ùÒòλµãÐòÁвéѯÇóÖú£¡
|
||||
|
ÓÐÎÄÏ×ÉÏ˵£º"Ñо¿·¢ÏÖ PDZK1£¨rs12129861£©»ùÒòλµãÓëÄòËáŨ¶ÈÃÜÇÐÏà ¹Ø"£¬ÇëÎÊÕâ¸ö»ùÒòλµãPDZK1£¨rs12129861£©Ôõô¶¨Î»£¬Ôõô²é¿´Æä»ùÒòÐòÁУ¿Íû¸÷λ³æÓÑÄܳé³öʱ¼ä¸øÓè°ïÖú¡£²»Ê¤¸Ð¼¤£¡ ˵Ã÷£ºPDZK1Ϊº¬ PDZ ½á¹¹Óòµ°°× 1£¨PDZ domain containing 1£¬PDZK1£© Óɺ¬ PDZ ½á¹¹Óò 1 »ùÒò±àÂ룬 ÊǶàÖÖתÔËÌåºÍµ÷½Úµ°°×µÄÖ§¼Üµ°°×£¬ÔÚÉö¡¢¸Î¡¢Ð¡³¦ºÍÉöÉÏÏÙÆ¤Öʱí´ï¡£ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¡¾·Ö×ÓÉúÎï¡¿EPIÌû |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ89È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
²ËÄñÇóÖú¡ª¡ª×ż±ÇóÖú½â´ð£ºÔÚNCBIÉÏΪʲôÏÂÔØ²»ÁËFASTA¸ñʽµÄ»ùÒòÐòÁÐ
ÒѾÓÐ9È˻ظ´
ÓÐËÖªµÀ¹ØÓÚPfrt I ÖÊÁ£µÄÐÅÏ¢£¬°üÀ¨ËûµÄ»ùÒòÐòÁкͺ¬ÓеÄøÇÐλµã¡£¼±°¡
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿Á½ÌõÐòÁÐÖ»ÓÐ1-2¸ö±äÒìλµã£¬ÄÜÉè¼ÆÌØÒìÒýÎïÇø±ð³öÀ´Âð£¿
ÒѾÓÐ23È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿»ùÒòÐòÁеķÖÎö
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔõÑù²éѯij¸öø»ùÒòµÄ»îÐÔλµã
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿NCBIÉÏ×¢²á»ùÒòÐòÁУ¬Ã»ÓÐACCESSION NUMEBERÊÇÔõô»ØÊ£¿Ð»Ð»
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿Ñ°ÕÒ»ùÒò×éÐòÁÐÖеĵ¥¿½±´»ùÒò
ÒѾÓÐ8È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿¹ØÓÚ»ùÒòÐòÁбȶÔ
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿À¶°×°ßɸѡʵÑéÔÀí
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÇëÎÊ£¬ÓÐûÓÐËÖªµÀ£¬ÈçºÎ´ÓNCBIÉÏÅúÁ¿ÏÂÔØÒ»ÀàgeneµÄºËÜÕËáÐòÁУ¿
ÒѾÓÐ13È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔõÑù´ÓÒ»¶ÎÐòÁÐÖвéÕÒ»ùÒò½á¹¹
ÒѾÓÐ12È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÒÑÖª»ùÒòÐòÁÐÈçºÎ¿Ë¡»ñµÃ
ÒѾÓÐ18È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
×ø±êÉϺ££¬³ÏÕ÷Å®ÓÑ£¬·Ç³£ ׿±£¬Ë½ÐűػØ
+1/461
µçÁ¦È«¹úÖØµãʵÑéÊÒ˫һÁ÷AÀ೤½Ñ§ÕßÍŶÓÕÐ2026ÄêÈ«ÈÕÖÆ²©Ê¿1Ãû£¨4ÔÂ3ÈÕ½ØÖ¹£©
+2/92
ÖзÉÔºº½¿Õï®µç³ØÍŶӽÓÊÜ˶ʿÉúµ÷¼Á
+1/86
»¯Ñ§»¯¹¤Ñ§Ôº ÕÐÊÕ»¯¹¤¡¢»¯Ñ§¡¢²ÄÁϵÈÏà¹Ø·½ÏòÑо¿Éú£¨Ñ§Ë¶¡¢×¨Ë¶¶¼Óе÷¼ÁÃû¶î£©
+1/83
º£ÄÏ´óѧ»¯¹¤ÔºÉúÎïÖʶ¨Ïòת»¯¿ÎÌâ×éÕÐÊÕ²©Ê¿/˶ʿ£¬2026Äê9ÔÂÈëѧ
+1/81
Æ®ÔÚÃÀ¹ú£¬ÓеãÏë¼Ò
+1/51
ÕÐÊÕ2026Äê²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á£¬É½¶«Ê¡ÊôÖØµã´óѧ£¬¹ý¹ú¼ÒÏß¼´¿Éµ÷¼Á£¬Ãû¶î³ä×ã
+2/46
»¶Ó½»Á÷×Éѯ
+1/42
Î÷ÄÏij211ÕÐ27½ì²©Ê¿
+1/12
¶àÂ×¶à´óѧ & Synetic Labs Õв©Ê¿ºó/Ñо¿Ô±
+1/8
ÖйúÖÐÒ½¿ÆÑ§ÔºÖÐÒ½Ò©½¡¿µ²úÒµÑо¿Ëù£¨½Î÷ÖÐÒ½Ò©½¡¿µ²úÒµÑо¿Ôº£©2026Äê¸ß²ã´ÎÈ˲ŵÈ
+1/7
ÖйúÃñº½·ÉÐÐѧԺÏȽøÁ¬½ÓÍŶÓÕÐÊÕº½¿ÕÓ¡¢º½¿Õ»úеרҵ˶ʿÑо¿Éú£¨Ñ§Ë¶×¨Ë¶¾ù¿É£©
+1/7
[Çóµ÷¼Á]Ö£ÖÝ´óѧÉúÎï¼¼Êõרҵ Ò»Ö¾Ô¸Õã´óÉú¿ÆÔº340·Ö
+1/7
Çൺ¿Æ¼¼´óѧ»¯¹¤Ñ§ÔºÔºÊ¿ÍŶÓ2026ÄêÄâÕÐÊÕÈ«ÈÕÖÆ²©Ê¿Ñо¿Éú1Ãû
+1/6
ÄϾ©ÁÖÒµ´óѧ»¯Ñ§¹¤³ÌѧԺ°ØÐÊ·å¿ÎÌâ×éÕÐÊÕ2026ÄêÉêÇ뿼ºËÖÆ²©Ê¿2Ãû
+1/4
26É격×Ô¼ö
+1/4
×Ü·Ö265¼ÆËã»úÇó¿çµ÷»·¾³
+1/3
2026¿¼ÑеÄͬѧ£¬·ÖÊý²»¹»£¿Ïëµ÷¼ÁÉϰ¶µÄͬѧ£¬À´¿´
+1/2
Ìì½ò´óѧÀíѧԺ·ÖÀë·ÖÎö¼°¹¦ÄܲÄÁÏÑо¿×é
+1/2
¡°»úе¡¢²ÄÁÏ¡±ÕÐÉú
+1/1
jinkui960
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- MolEPI: 22
- Ó¦Öú: 1220 (½²Ê¦)
- ½ð±Ò: 10246.5
- Ìû×Ó: 5797
- ÔÚÏß: 517.3Сʱ
- ³æºÅ: 1327313
4Â¥2011-08-08 11:04:54
jinkui960
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- MolEPI: 22
- Ó¦Öú: 1220 (½²Ê¦)
- ½ð±Ò: 10246.5
- Ìû×Ó: 5797
- ÔÚÏß: 517.3Сʱ
- ³æºÅ: 1327313
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RhythmQiu(½ð±Ò+5):лл²ÎÓë
dhd997(½ð±Ò+5, MolEPI+1): good 2011-08-08 18:23:04
RhythmQiu(½ð±Ò+5):лл²ÎÓë
dhd997(½ð±Ò+5, MolEPI+1): good 2011-08-08 18:23:04
|
rs12129861ÊÇ PDZK1»ùÒòÔÚdbSNPÊý¾Ý¿âµÄIDºÅÂ룬dbSNPÊý¾Ý¿âµÄÍøÕ¾µØÖ·ÈçÏ£º http://www.ncbi.nlm.nih.gov/projects/SNP/ PDZK1ÓжàÖÖSNP£¬¼´PDZK1»ùÒò´æÔÚ¶àÖÖµ¥ºËÜÕËá¶à̬ÐÔ£¬rs12129861ÊÇPDZK1»ùÒò·¢ÉúÁËÒ»¸öµ¥ºËÜÕËá¶à̬ÐÔ£¨A/G£©±ä»¯¡£ ¶ÔÓ¦µÄÐòÁУº >gi|224514973:1053161-1053391 Homo sapiens chromosome 1 genomic contig, GRCh37.p5 Primary Assembly AGGGTCGTGTGTTACCACCTAAGCAGGAATCCCCCAAAGTTCTGCCCTATATTTGGACATCATGTAAATGGAATCCTAGTATGAAAATGAATGAACTACAGCTACTCACAGCAACGTGAGTGAACCTCACAAACATCATATTGAATGAAATAAACCAGAGACAAAAGGAATACACCAGGCCTGTAATCCCAGTACTTTGGGAGGCCAAGGCGGGAGGATCACTTGAGGTCA ¶ÔÓ¦µÄ»ùÒòÃèÊö¼ûÍøÒ³£º http://www.ncbi.nlm.nih.gov/site ... amp;term=rs12129861 Ïà¹ØµÄÎÄÏ×ÈçÏ£º 1) Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T, Hengstenberg C. PLoS One. 2009 Nov 5;4(11):e7729. 2) Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, Navis G. Hum Mol Genet. 2010 Jan 15;19(2):387-95. Epub 2009 Oct 27. 3) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M, Albrecht E, Wallace C, Farrall M, Johansson A, Nyholt DR, Aulchenko Y, Beckmann JS, Bergmann S, Bochud M, Brown M, Campbell H; EUROSPAN Consortium, Connell J, Dominiczak A, Homuth G, Lamina C, McCarthy MI; ENGAGE Consortium, Meitinger T, Mooser V, Munroe P, Nauck M, Peden J, Prokisch H, Salo P, Salomaa V, Samani NJ, Schlessinger D, Uda M, V?lker U, Waeber G, Waterworth D, Wang-Sattler R, Wright AF, Adamski J, Whitfield JB, Gyllensten U, Wilson JF, Rudan I, Pramstaller P, Watkins H; PROCARDIS Consortium, Doering A, Wichmann HE; KORA Study, Spector TD, Peltonen L, V?lzke H, Nagaraja R, Vollenweider P, Caulfield M; WTCCC, Illig T, Gieger C. PLoS Genet. 2009 Jun;5(6):e1000504. Epub 2009 Jun 5. [ Last edited by jinkui960 on 2011-8-8 at 11:54 ] |
3Â¥2011-08-08 11:00:20













»Ø¸´´ËÂ¥